Successful phase 3 trial of drug for liver cancer
An international phase 3 trial has found that the drug regorafenib improved survival in patients with advanced hepatocellular carcinoma (HCC), a form of liver cancer, giving people who previously had no other options a better ...
Jan 18, 2017